Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of AntiCancer patents

Patents where

Current Assignee

Name

‌

AntiCancer

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11001826 Orally administered composition to lower serum methionine levels and method of use	Patent 11001826 was granted and assigned to AntiCancer on May, 2021 by the United States Patent and Trademark Office.	‌ AntiCancer	‌ AntiCancer	United States Patent and Trademark Office	11001826	May 11, 2021
‌ US Patent 7556825 Method for promoting hair growth	Patent 7556825 was granted and assigned to AntiCancer on July, 2009 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	7556825	July 7, 2009
‌ US Patent 7625550 Enhanced resolution of tumor metastasis using a skin flap model	Patent 7625550 was granted and assigned to AntiCancer on December, 2009 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	7625550	December 1, 2009
‌ US Patent RE39337 Nude mouse model for human neoplastic disease	Patent RE39337 was granted and assigned to AntiCancer on October, 2006 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	RE39337	October 10, 2006
‌ US Patent 7264819 Lyase treatment for	Patent 7264819 was granted and assigned to AntiCancer on September, 2007 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	7264819	September 4, 2007
‌ US Patent 7799549 Methods for increasing protein polyethylene glycol (PEG) conjugation	Patent 7799549 was granted and assigned to AntiCancer on September, 2010 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	7799549	September 21, 2010
‌ US Patent 8465734 Methods for increasing protein polyethylene glycol (PEG) conjugation	Patent 8465734 was granted and assigned to AntiCancer on June, 2013 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	8465734	June 18, 2013
‌ US Patent 8148600 Immunocompromised rodents as dual color tumor models	Patent 8148600 was granted and assigned to AntiCancer on April, 2012 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	8148600	April 3, 2012
‌ US Patent 8822194 Cancer selective auxotrophs	Patent 8822194 was granted and assigned to AntiCancer on September, 2014 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	8822194	September 2, 2014
‌ US Patent 9464312 Schiff-base conjugate of N, N-dibutyl-P-phenylenediamine with pyridoxal 5′-phosphate for improved homocysteine assays using pyridoxal 5′-phosphate-dependent enzymes	Patent 9464312 was granted and assigned to AntiCancer on October, 2016 by the United States Patent and Trademark Office.	‌ AntiCancer	‌ AntiCancer	United States Patent and Trademark Office	9464312	October 11, 2016
‌ US Patent 9539290 Individualized bacterial treatment of pancreatic cancer	Patent 9539290 was granted and assigned to AntiCancer on January, 2017 by the United States Patent and Trademark Office.	‌ AntiCancer	‌ AntiCancer	United States Patent and Trademark Office	9539290	January 10, 2017
‌ US Patent 7666675 Nestin-expressing hair follicle stem cells	Patent 7666675 was granted and assigned to AntiCancer on February, 2010 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	7666675	February 23, 2010
‌ US Patent 7252941 Expression profiling based on histocultures	Patent 7252941 was granted and assigned to AntiCancer on August, 2007 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	7252941	August 7, 2007
‌ US Patent 7329516 Methods for increasing protein polyethylene glycol (PEG) conjugation	Patent 7329516 was granted and assigned to AntiCancer on February, 2008 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	7329516	February 12, 2008
‌ US Patent 8481318 Nestin-expressing hair follicle stem cells	Patent 8481318 was granted and assigned to AntiCancer on July, 2013 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	8481318	July 9, 2013
‌ US Patent 6916793 Selenium-containing pro-drugs for cancer therapy	Patent 6916793 was granted and assigned to AntiCancer on July, 2005 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	6916793	July 12, 2005
‌ US Patent 6905831 Real time measurement of cellular responses	Patent 6905831 was granted and assigned to AntiCancer on June, 2005 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	6905831	June 14, 2005
‌ US Patent 7067496 Methods for introducing genes into mammalian subjects	Patent 7067496 was granted and assigned to AntiCancer on June, 2006 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	7067496	June 27, 2006
‌ US Patent 6844326 Treatment of alopecia	Patent 6844326 was granted and assigned to AntiCancer on January, 2005 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	6844326	January 18, 2005
‌ US Patent 6927038 Total cysteine assay	Patent 6927038 was granted and assigned to AntiCancer on August, 2005 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	6927038	August 9, 2005
‌ US Patent 11871731 Transplantation method to increase the establishment rate of human tumors in immunodeficient mice	Patent 11871731 was granted and assigned to AntiCancer on January, 2024 by the United States Patent and Trademark Office.	‌ AntiCancer	‌ AntiCancer	United States Patent and Trademark Office	11871731	January 16, 2024
‌ US Patent 12023370 Composition for the treatment of COVID-19 infection, and a method of treatment	Patent 12023370 was granted and assigned to AntiCancer on July, 2024 by the United States Patent and Trademark Office.		‌ AntiCancer	United States Patent and Trademark Office	12023370	July 2, 2024

22 results

0 selected

22 results

0 selected